Palvella Therapeutics (PVLA) Other Non-Current Assets (2015 - 2023)

Palvella Therapeutics (PVLA) has 9 years of Other Non-Current Assets data on file, last reported at $287000.0 in Q3 2023.

• Quarterly Other Non-Current Assets fell 78.04% year-over-year to $287000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $287000.0 (down 78.04% YoY) and the FY2022 annual result came in at $1.4 million, down 52.86% from the prior year.
• Other Non-Current Assets retreated to $287000.0 in Q3 2023 per PVLA's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $11.5 million in Q2 2019 and bottomed at $287000.0 in Q3 2023.
• The 5-year median for Other Non-Current Assets is $2.4 million (2022), against an average of $2.9 million.
• The widest annual swing landed in 2019, when Other Non-Current Assets surged 8806.98%; it then tumbled 82.81% in 2020.
• Tracing PVLA's Other Non-Current Assets over 5 years: stood at $3.1 million in 2019, then increased by 5.18% to $3.3 million in 2020, then retreated by 12.24% to $2.9 million in 2021, then plunged by 52.86% to $1.4 million in 2022, then sank by 79.04% to $287000.0 in 2023.
• Per Business Quant, the three latest PVLA Other Non-Current Assets figures stand at $287000.0 (Q3 2023), $1.1 million (Q2 2023), and $1.3 million (Q1 2023).

Peer Comparison